claim: Based on the Creighton cancer and osteoporosis study
identity: DIETARY SUPPLEMENT
claim: Nx
other: Suggested Use: The dose used in the Creighton Study corresponded to 6 tablets per day for a person weighing 147 lbs (67 kg). This dosage can be scaled down for lighter persons, and taken in divided doses, such as 3 tablets 2 times/day.
claim: A clinical trial known as the Creighton Study (CS) revealed in 2007 that a daily supplement of vitamin D3 plus calcium can reduce one's cancer risk by 77%. The study also showed a significant gain in bone strength. Formula CS Plus duplicates the Creighton formula, but with additional bone-enhancers included. For details see: http://lifelinknet.com/sieResources/Products/Formula-CS-Plus.asp
Label facts as declared by the manufacturer to the NIH Dietary Supplement Label Database (DSLD), not independently
lab-tested. This page reports what the label says; it does not rate, score, or recommend this product.